These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Control of intracellular delivery of oligonucleotides by signal peptides and genetic expression in human cells. Kubo T, Kanno K, Ohba H, Rumiana B, Fujii M. Nucleic Acids Symp Ser (Oxf); 2004; (48):303-4. PubMed ID: 17150599 [Abstract] [Full Text] [Related]
4. Inhibition of HIV-1 replication by a new type of circular dumbbell RNA/DNA chimeric oligonucleotides. Park WS, Miyano-Kurosaki N, Abe T, Takai K, Yamamoto N, Takaku H. Biochem Biophys Res Commun; 2000 Apr 21; 270(3):953-60. PubMed ID: 10772932 [Abstract] [Full Text] [Related]
5. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Reed JC, Stein C, Subasinghe C, Haldar S, Croce CM, Yum S, Cohen J. Cancer Res; 1990 Oct 15; 50(20):6565-70. PubMed ID: 2208117 [Abstract] [Full Text] [Related]
6. Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia. Pfundt R, van Ruissen F, van Vlijmen-Willems IM, Alkemade HA, Zeeuwen PL, Jap PH, Dijkman H, Fransen J, Croes H, van Erp PE, Schalkwijk J. J Clin Invest; 1996 Sep 15; 98(6):1389-99. PubMed ID: 8823304 [Abstract] [Full Text] [Related]
14. Inhibition of interferon-gamma-induced intercellular adhesion molecule-1 expression on human keratinocytes by phosphorothioate antisense oligodeoxynucleotides is the consequence of antisense-specific and antisense-non-specific effects. Hertl M, Neckers LM, Katz SI. J Invest Dermatol; 1995 May 15; 104(5):813-8. PubMed ID: 7738361 [Abstract] [Full Text] [Related]
15. Relative levels of inhibition of p24 gene expression by different 20-mer antisense oligonucleotide sequences targeting nucleotides + 1129 to + 1268 of the HIV-1 gag genome: an analysis of mechanism. Anazodo MI, Duta E, Friesen AD, Wright JA. Biochem Biophys Res Commun; 1996 Dec 04; 229(1):305-9. PubMed ID: 8954123 [Abstract] [Full Text] [Related]
16. Inhibitory effect of EGFR antisense oligodeoxynucleotide on human hepatoma cell line. Gong ZB, Liu JM, Li YM. Hepatobiliary Pancreat Dis Int; 2005 Aug 04; 4(3):433-6. PubMed ID: 16109531 [Abstract] [Full Text] [Related]
17. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence. Zupi G, Scarsella M, Semple SC, Mottolese M, Natali PG, Leonetti C. Clin Cancer Res; 2005 Mar 01; 11(5):1990-8. PubMed ID: 15756025 [Abstract] [Full Text] [Related]
18. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides. Galderisi U, Di Bernardo G, Melone MA, Galano G, Cascino A, Giordano A, Cipollaro M. J Cell Biochem; 1999 Jul 01; 74(1):31-7. PubMed ID: 10381259 [Abstract] [Full Text] [Related]
20. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation. Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, Cho-Chung YS. Clin Cancer Res; 2002 Feb 01; 8(2):607-14. PubMed ID: 11839683 [Abstract] [Full Text] [Related] Page: [Next] [New Search]